Skip to main content
Premium Trial:

Request an Annual Quote

Insilicos Gets $900K Grant to Further Develop Statistical Models

NEW YORK (GenomeWeb News) – Insilicos has received a $900,000 grant from the National Institute of General Medical Sciences to further develop a statistical modeling method for biomedical research.
 
Specifically, Insilicos will apply the funds to further development of Ensemble Learning, which is a technique that uses a committee of statistical models to make a more accurate prediction than can be achieved with a single model. The technique is particularly well-suited to large data sets of biomedical research, said Insilicos.
 
The Seattle-based firm said that the challenge of Ensemble Learning is that it requires extensive calculations that requires hours or even days. Insilicos believes that using the technique with cloud computing technology will “make this approach highly scalable, fast, and cost effective for a wide range of problems.”

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.